glp-1 receptor agonists and sglt2 inhibitors Complementary Yet Distinct Roles of in Cardiovascular Risk Reduction Complementary Yet Distinct Roles of
Description
The primary outcome was the new onset of adverse CVEs, including heart failure, composite incidence of major adverse cardiovascular events (MACE

For higher or adjustable dosing options, please refer to our standard GLP-1 program

Conclusion arGLP-1 are effective and safe for managing IWL or WR after BS, leading to significant weight loss, comorbidity improvement, and sustained %TWL

Prescription product

Methods A retrospective study was conducted using electronic medical records from 2014 to 2019 for adults with T2D at the Valencia Clnico-Malvarrosa Department of Health (Valencia, Spain)
